Rockefeller Capital Management L.P. Cara Therapeutics, Inc. Transaction History

Rockefeller Capital Management L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 06, 2023	SELL	$8.88 - $12.77 $11,810 - $16,984	-1,330 Reduced 56.33%	1,031 $11,000
Q3 2022 Nov 02, 2022	SELL	$8.24 - $12.56 $1,672 - $2,549	-203 Reduced 7.92%	2,361 $22,000
Q2 2022 Aug 12, 2022	BUY	$7.45 - $13.84 $1,683 - $3,127	226 Added 9.67%	2,564 $23,000
Q1 2022 May 13, 2022	BUY	$9.94 - $12.65 $29 - $37	3 Added 0.13%	2,338 $28,000
Q3 2021 Nov 12, 2021	BUY	$11.55 - $16.06 $9,297 - $12,928	805 Added 52.61%	2,335 $36,000
Q2 2021 Aug 10, 2021	BUY	$12.38 - $29.19 $6,561 - $15,470	530 Added 53.0%	1,530 $21,000
Q1 2021 May 11, 2021	SELL	$15.07 - $21.71 $45,210 - $65,130	-3,000 Reduced 75.0%	1,000 $21,000
Q4 2020 Feb 12, 2021	SELL	$12.72 - $16.16 $12,720 - $16,160	-1,000 Reduced 20.0%	4,000 $60,000
Q1 2020 May 12, 2020	SELL	$9.12 - $17.78 $36,480 - $71,120	-4,000 Reduced 44.44%	5,000 $66,000
Q3 2019 Nov 12, 2019	BUY	$18.28 - $26.91 $164,520 - $242,190	9,000 New	9,000 $165,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.